COMMUNIQUÉS West-GlobeNewswire

Press Release Biocartis NV: Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer
09/06/2026
PRESS RELEASE, 06/09/2026, 08:00 CDT Biocartis Announces Agreement with City of Hope to Explore Development of Rapid Gene Signature Test for Early Detection of Pancreatic Cancer Itasca, IL, US, 09 June 2026 – Today, [...]
Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year
09/06/2026
WICHITA, Kan., June 09, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living ® has earned Great Place to Work ® Certification ™ for the eighth consecutive year, a distinction based entirely on feedback from associates through [...]
Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand
09/06/2026
The partnership brings Nucleus’ advanced carrier and embryo screening to Hawaii’s largest IVF practice NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today announced an IVF+ partnership with the Fertility [...]
AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
09/06/2026
Acquisition strengthens end-to-end support for Limited English Proficiency (LEP) patients by pairing high-quality AI assistance with AMN’s trusted human interpreter services DALLAS, June 09, 2026 (GLOBE NEWSWIRE) -- AMN [...]
BPC-157 Research Peptide: Koi Peptides Launches a COA-Verified Reference Compound for Laboratory Use
09/06/2026
Cheyenne, Wyoming, June 09, 2026 (GLOBE NEWSWIRE) -- Koi Peptides has launched BPC-157, a synthetic pentadecapeptide, as a research-use-only reference compound for laboratory use. Each batch is characterized by HPLC for [...]
Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium
09/06/2026
Presentation to highlight fibrostenotic Crohn’s disease biology and the potential of a locally bioactivated PDE4 inhibitor prodrug approach Denver, CO, June 09, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI [...]
International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje
09/06/2026
Awarding ceremonies to be held today, June 9, 2026, at the 17th Annual IMWG Summit in Stockholm, Sweden STOCKHOLM, June 09, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the International [...]
Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer
09/06/2026
Discussion explores challenges of immunologically “cold” tumors and the potential for scalable engineered cell therapies to expand patient access in oncology Access the segment here CAMBRIDGE, Mass., June 09, 2026 ( [...]
Imviva Biotech Receives FDA Investigational New Drug Approval for CTA313, a Dual-Targeted CD19/BCMA Allogeneic CAR-T Cell Therapy for Autoimmune Diseases
09/06/2026
Approval paves the way for CTA313 clinical study in the United States for patients with systemic lupus erythematosus, progressive multiple sclerosis, and autoimmune encephalitis BOSTON, June 09, 2026 (GLOBE NEWSWIRE [...]
Vericel to Present at the 2026 Truist Securities MedTech Conference on Tuesday, June 16, 2026
09/06/2026
BURLINGTON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
09/06/2026
Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approval On track for expected CRL response submission by end of [...]
Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
09/06/2026
First Midwest-based account reflects continued execution of the Company's Full Market Release strategy and expansion into additional U.S. territories HINGHAM, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Microbot Medical [...]
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
09/06/2026
AI-based platform, ‘Ask Oscar™’, to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation barriers See Ask Oscar in action: https://envuemed.com/ask- [...]
Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022
09/06/2026
MyGenome Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening its Position in Southeast Asian Genomics KUALA LUMPUR, Malaysia, June 09 [...]
SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team
09/06/2026
Commercial Launch Planned for Mid-July; 5,000+ Healthcare Facilities Reached Through GPO Agreements, Covering ~60% of Institutional GPO Market U.S. naloxone market totals ~$144 million in annual sales and ~9.8 million [...]
Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program
09/06/2026
Selection by both the NIA ITP and ARPA-H PROSPR programs highlights growing recognition of LNS8801’s potential to promote healthy aging HADDONFIELD, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Linnaeus Therapeutics, Inc., a [...]
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
09/06/2026
COPD study initiation expands WIN378 development into a second major respiratory disease WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half [...]
R1 Appoints Eric Tagliere as Chief Information Officer
09/06/2026
CHICAGO, June 09, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced that Eric Tagliere has joined the Company as Chief Information Officer. In this role, [...]
Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis
09/06/2026
Geleen, June 9, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast [...]

Pages